Movement Disorder Market: Global Size, Share, Trends, Growth and Forecast, 2022-2032
Healthcare & PharmaceuticalRequest PDF Sample Request Discount
- Status : Upcoming
- Published on: Jan 2022
- Report ID: KDMI-6849
- Available Format: PDF/Excel/DOC
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Movement Disorder MarketRequest PDF Sample
The movement disorder is abnormality in the velocity of the movement of the body. The term ‘movement disorder’ has become similar with basal ganglia disease and extrapyramidal features. It affects brain, spinal cord and nerves throughout the body leading to cerebrovascular diseases, degenerative diseases of adult life etc. Abnormality of movement may be the only reflexion of a disease process, or may be part of a more extensive neurological disorder. The nerves of the entire body get affected resulting in various cerebrovascular diseases that are degenerative in nature. The common adult movement disorder is Essential tremor (ET) as much as 20 times more frequent than Parkinson's disease. The lack in the production of brain chemical dopamine by the nerve cells in the brain leads to clumsy movements and mental disorders that result in impacting everyday activities of people.
The overwhelming advancement of the technology have given rise to new and advance level of treatment that will absolutely mark the growth of the market in the coming years.
The factors such as convulsive diseases, degenerative diseases, brain tumors increase due to inability to move around and all these factors adversely impact the global movement disorders market. Human life gets complicated by the neurological disorders as it affects the cognitive abilities of a human being. All these complications led to inability to chew food, to swallow, insomnia, and depression too and with the increasing in awareness attributed to growth in prevalence of the neurological diseases led to growth of the global movement disorders market graph upward.
Medications and treatments approved by FDA is also expected to impact growth of the global movement disorder market. Xadago (safinamide) tablets and Ingrezza capsules are two drugs that have recently cleared the FDA pipeline. Ingrezza capsules have recently received approval for treatment of dyskinesia and Xadago (safinamide) tablets have received approval of Parkinson’s disease. In addition, the FDA has also approved implantation of brain to reduce the tremor symptoms. These factors are further expected to boost growth of the global movement disorders market.
By Product Type
- Rechargeable Deep Brain Stimulator Devices
- Non-rechargeable Deep Brain Stimulator Devices
By Disease Type
- Parkinson’s disease
- Restless legs syndrome
- Huntington’s disease
By End User
- Ambulatory Surgical Centers
- North America
- Asia Pacific
- Middle East & Africa
- Latin America
North America accounted for largest market in movement disorder market. Factors such as high healthcare spending, high prevalence of diseases, technological advancements and increasing awareness are major factors which are anticipated to bolster the growth of market. Asia Pacific offers significant growth opportunities for major players across the globe. Huge population, rising number of geriatric population, and growing healthcare infrastructures are positively impacting the growth of market.
- Abbott Laboratories,Inc
- Baxter International, Inc
- Cardinal Health
- Boston Scientific Corporation
- Forest Laboratories
- Hospira, Inc
- Hoffmann-La Roche AG
- Medtronic, Inc
- Merck Serono
- Mylan Pharmaceuticals
- Other Players
Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).
The study also provides company’s positioning and market share in movement disorder market.
Timeline Considered for Analysis:
- 2019: Base Year
- 2020: Estimated Year
- 2020 to 2025: Forecast Period
Research Scope and Deliverables
Overview & Executive Summary
Market Drivers, Trends, Challenges and Opportunities
Market Size and Forecast Projections
Macroeconomic Indicators of Various Countries Impacting the Growth of the Market
Extensive Coverage of Industry Players including Recent Product Launches and Market Activities
Porter’s Five Force Analysis
Market Segmentation Analysis:
Industry report analyses the global movement disorder market by the following segments:
- Product Type
- Disease Type
- End User
Customization: We also offer customization’s in the industry report as per the company’s specific needs.
Key Questions Answered in the Global Movement Disorder Industry Report
- What is the overall market size in 2019? What will be the market growth during the forecast period i.e. 2020-2025?
- Which region would have high demand for product in the upcoming years?
- What are the factors driving the growth of the market?
- Which sub-market will make the most significant contribution to the market?
- What are the market opportunities for existing and entry-level players?
- What are various long-term and short-term strategies adopted by the market players?
Custom Research Requirement? Questions to ask?Get in touch
Custom Research requirement.